Atika Capital Management LLC Bristol Myers Squibb CO Call Options Transaction History

Atika Capital Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $3.66 Million - $4.74 Million	-75,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $3.79 Million - $4.72 Million	-75,000 Reduced 50.0%	75,000 $4.15 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $5.17 Million - $5.95 Million	86,300 Added 135.48%	150,000 $9.49 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $821,178 - $895,294	13,700 Added 27.4%	63,700 $3.9 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $2.76 Million - $3.19 Million	50,000	50,000 $3.19 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.